Skip to main content
. Author manuscript; available in PMC: 2013 Jun 14.
Published in final edited form as: Cancer Gene Ther. 2010 Aug 20;17(12):883–892. doi: 10.1038/cgt.2010.46

Figure 6.

Figure 6

IL-12 and IFNγ levels in the tumors and spleens of tumor-bearing mice treated with rM51R-M virus or IL-12 plasmid DNA. Tumors and spleens from tumor-bearing mice were harvested at days 7 and 14 post-treatment and assayed for the presence of IL-12 p40 (a and b) and IFNγ (c) by enzyme-linked immunosorbent assay (ELISA). Data represent the average ± s.d. of a total of 3–5 mice from two experiments.